Chimera Investment (NYSE:CIM) Upgraded to Hold at Wall Street Zen

Chimera Investment (NYSE:CIMGet Free Report) was upgraded by stock analysts at Wall Street Zen from a “sell” rating to a “hold” rating in a report issued on Sunday.

CIM has been the subject of several other reports. Weiss Ratings lowered Chimera Investment from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Wednesday, May 20th. Royal Bank Of Canada reiterated a “sector perform” rating and set a $14.00 target price on shares of Chimera Investment in a research report on Wednesday, June 3rd. One research analyst has rated the stock with a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, Chimera Investment currently has an average rating of “Hold” and an average price target of $14.83.

Check Out Our Latest Analysis on Chimera Investment

Chimera Investment Stock Performance

Shares of NYSE CIM opened at $13.66 on Friday. Chimera Investment has a 12-month low of $11.67 and a 12-month high of $14.88. The firm has a market capitalization of $1.14 billion, a price-to-earnings ratio of -17.08 and a beta of 1.68. The company has a current ratio of 0.08, a quick ratio of 0.08 and a debt-to-equity ratio of 2.31. The firm has a 50 day moving average of $13.41 and a 200 day moving average of $13.15.

Chimera Investment (NYSE:CIMGet Free Report) last released its quarterly earnings results on Thursday, May 7th. The real estate investment trust reported $0.54 earnings per share for the quarter, topping the consensus estimate of $0.52 by $0.02. The business had revenue of $32.37 million for the quarter, compared to the consensus estimate of $102.35 million. Chimera Investment had a net margin of 2.27% and a return on equity of 9.36%.

Institutional Trading of Chimera Investment

Several institutional investors and hedge funds have recently modified their holdings of CIM. SG Americas Securities LLC purchased a new position in shares of Chimera Investment during the 4th quarter valued at $7,431,000. UBS Group AG boosted its holdings in Chimera Investment by 130.7% in the 4th quarter. UBS Group AG now owns 763,691 shares of the real estate investment trust’s stock worth $9,493,000 after buying an additional 432,727 shares during the period. Ritholtz Wealth Management purchased a new stake in Chimera Investment in the 4th quarter worth $4,977,000. Millennium Management LLC increased its stake in Chimera Investment by 65.8% in the 4th quarter. Millennium Management LLC now owns 697,620 shares of the real estate investment trust’s stock worth $8,671,000 after buying an additional 276,950 shares in the last quarter. Finally, Two Sigma Investments LP increased its stake in Chimera Investment by 88.7% in the 3rd quarter. Two Sigma Investments LP now owns 574,456 shares of the real estate investment trust’s stock worth $7,594,000 after buying an additional 270,034 shares in the last quarter. 48.44% of the stock is currently owned by institutional investors.

Chimera Investment Company Profile

(Get Free Report)

Chimera Investment Corporation (NYSE: CIM) is a publicly traded real estate investment trust that specializes in investing in residential mortgage assets. The company’s portfolio primarily consists of agency and non-agency residential mortgage-backed securities, whole loan residential mortgages and other mortgage-related assets. As a REIT, Chimera Investment aims to generate attractive risk-adjusted returns through its focus on high-quality collateral and disciplined risk management.

The firm’s core business activities include identifying and acquiring portfolios of residential mortgage loans and securities from financial institutions and in the secondary market.

Featured Articles

Receive News & Ratings for Chimera Investment Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chimera Investment and related companies with MarketBeat.com's FREE daily email newsletter.